Business Wire

World First: Autonomous Racing Leaps Forward in Abu Dhabi as A2RL Season 2 Showcases Record Speed, Bold Overtakes and Real-Time AI Decision-Making

17.11.2025 14:50:00 CET | Business Wire | Press Release

Share

The Abu Dhabi Autonomous Racing League, A2RL, delivered a defining moment for autonomous technology as six fully driverless racecars pushed the limits of AI performance in a world-first Grand Final at Yas Marina Circuit. In a night marked by record speed, bold overtakes, and split-second AI decision-making, Germany’s TUMcemented its dominance by retaining the championship title, followed by TII Racing (UAE) in second place, and PoliMOVE (Italy) in third. With eleven international teams battling for a $2.25 million prize pool and a Human vs AI showdown featuring former F1 star Daniil Kvyat, the event showcased just how dramatically the race - and the technology behind it - has advanced since Season 1.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117644875/en/

World First: Autonomous Racing Leaps Forward in Abu Dhabi as A2RL Season 2 Showcases Record Speed, Bold Overtakes and Real-Time AI Decision-Making (Photo: AETOSWire)

From the moment the race began, polesitters TUM were under pressure from Unimore (Italy), who showcased their own record-setting pace to catch and overtake them for the lead in Turn 6 before the end of the second lap. Over the course of the next ten laps, the duo continued to battle at speeds ofover 250 km/h, with less than a second between them throughout. At the half-way stage of the 20-lap race, the pair were within half a second of one another as they met the back of the pack. Going for the overtake on sixth place Constructor (Germany), Unimore collided with the rear of the car mid corner, sending both cars off track and handing the lead back to TUM who then carried through to victory. Unimore claimed the Fastest Lap Award through the duration of the competition.

Trophies and medals were presented to the winners of the A2RL Grand Final by His Highness Sheikh Zayed bin Mohamed bin Zayed Al Nahyan, His Highness Sheikh Mohammed bin Sultan bin Khalifa Al Nahyan, Vice-Chairman of the Abu Dhabi International Marine Sports Club and Chairman of the UAE Marine Sports Federation, and His Excellency Faisal Al Bannai, Adviser to the UAE President and Secretary General of the Advanced Technology Research Council.

H.E. Faisal Al Bannai, who envisioned A2RL, said: “A2RL shows what happens when bold ambition meets scientific discipline. It is more than a race - it is a testbed accelerating the future of autonomous systems while building public trust in the technologies that will soon move through our cities, skies and industries. What unfolded on track reflects the power of global talent, rigorous research, and the UAE’s conviction that breakthroughs happen faster when you invite the world to innovate with you.”

Prof. Markus Lienkamp, Team Principal at TUM, said: “We expected a tight battle with Unimore behind us from the beginning. They have been getting faster and faster in every test session, especially on cold tyres. We expected they’d overtake us on lap two and then we would get closer as our tyres warmed up. Of course, we hoped to see action with Unimore all the way to the end, but regardless what we have shown tonight is the rapid improvement and professional capability of the teams in this championship, to be able to have such a close battle in front of the crowd tonight.”

Marko Bertogna, Team Principal, Unimore Racing, said: “I was very, very happy with the performance that we showed, our speed, the overtake, all showed the professional level that we have reached. Even a human racing driver would not have been able to avoid the collision we had, so this is just the nature of high-performance racing. I’m incredibly happy about the technological result, but of course less happy about the final result.”

In only its second season, A2RL and participating teams have demonstrated significant progress at the crossroads of motorsport, mobility, and AI. Often referred to as “science in the public domain”, A2RL is accelerating the development of high-performance autonomous racing technology by putting it under extreme competitive pressure.

Intensive qualifying in recent weeks saw AI-driven cars not only closing the gap with human benchmark lap times but surpassing them - moving from minutes behind to mere fractions of a second ahead. The Grand Final set a record as the largest autonomous race in the world, featuring six teams: TUM, Unimore, Kinetiz (UAE), TII Racing, PoliMOVE and Constructor (in order of the starting pole positions).

Man vs Machine: Daniil Kvyat takes on Champion’s AI driver

Former Formula 1 racer Daniil Kvyat was stunned by the progress teams had made since he last went head-to-head with an AI driver during a 2024 A2RL exhibition in Japan. This time, he was on track with reigning champion TUM’s autonomous car HAILEY. Beginning from a rolling start with a 10 second gap, Kvyat was given just ten laps to hunt down his AI competitor. Kvyat marked his best lap at 57.57 seconds, while HAILEY recorded its best lap at 59.15 seconds – leaving just 1.58 seconds between them, a dramatic shift from the 10-second gulf just 18 months ago and a clear sign that AI is catching up fast. The showcase ended with the duo roaring across the line in close succession, much to the delight of fans in the grandstand.

Daniil Kvyat, commented: “Looking back to when A2RL development first began a couple of years ago, with perhaps minutes between a human driver and the AI car, down to 10 seconds in our first showcase last year, and now we are seeing performance within fractions of a second – the technology progress is staggering. As a technology enthusiast and a racer, it’s fantastic to be a part of this development since the beginning. Being on track with an AI driver is unlike anything else and it was fun to bring an exciting battle to the fans this evening.”

Stephane Timpano, CEO of ASPIRE, the ATRC entity driving A2RL commented: “Congratulations to TUM on a remarkable win. This Grand Final proved exactly why A2RL exists: to push the boundaries of autonomous technology through real competition. In just 18 months, teams have gone from standing still to delivering human-beating lap times and mastering complex overtakes - progress that can take years. By combining virtual SIM Sprints with extensive real-world testing, they’ve unlocked capabilities that will influence far more than racing. My thanks to all eleven teams for showing what true innovation under pressure looks like.”

A2RL also hosted a STEM Competition in parallel to the main competition. Over 140 students from across all seven Emirates in the UAE participated in an educational program that culminated in racing DeepRacer 1/18th-scale autonomous cars, a mirror of the A2RL competition. It aims to inspire and enable the next generation of autonomy and AI specialists, equipping them with new skills and experience. This year, the winner of the University League was ‘UAE University’, while ‘SABIS - Ras Al Khaimah’ claimed the High Schools title.

This year’s A2RL Grand Final was the capstone to the first-ever Abu Dhabi Autonomous Week (ADAW), a six-day event bringing together researchers and industry experts across a series of high-profile summits, exhibitions, and events. ADAW includes the Abu Dhabi Autonomous Summit, DRIFTx Exhibition, and RoboCup Asia-Pacific.

A2RL Season 2 was attended by over 8,000 spectators, filling capacity at the North Grandstand. It is supported by SteerAI, alongside leading partners du infra and AD Ports Group, official partners AWS and Abu Dhabi Mobility; official supporters WIO Bank PHSC, Exxon Mobil and Castore; technical partners PACETEQ, Live in Five, Meccanica 42, and Vislink; as well as event partners Abu Dhabi Gaming, Miral - Yas Island, and the UAE Cybersecurity Council.

Watch the race here: https://youtu.be/d9LLZ5mb5cA?si=RgJnvjWhdasZdXZS

View source version on businesswire.com: https://www.businesswire.com/news/home/20251117644875/en/

Contacts

Naomi Panter
naomi@navigate.partners

Alexandra Patel
alexandra.patel@edelman.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Vertex Announces US FDA Approval for Label Extensions of ALYFTREK ® and TRIKAFTA ® , Expanding Availability of These Medicines to ~95% of All People With CF in the United States1.4.2026 13:30:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved expanded use of ALYFTREK® (vanzacaftor/tezacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 6 and older with a variant in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is either responsive based on clinical and/or in vitro data or results in production of CFTR protein. Additionally, the U.S. FDA has also expanded the indication statement for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in patients ages 2 and older. This label expansion was supported by clinical and/or in vitro data from 564 variants demonstrating response to ALYFTREK and 521 variants demonstrating response to TRIKAFTA. As such, approximately 800 more people with a clinical diagnosis of CF in the U.S. are now eligible for a medicine that treats the underlying cause of their disease for the first time. This extension means approxim

Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer1.4.2026 13:30:00 CEST | Press Release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the first patient has been enrolled in the landmark global phase 3 BATTMAN (CO.33) trial (NCT07152821). This study is evaluating Agenus’ immunotherapy combination of botensilimab (BOT) plus balstilimab (BAL) versus best supportive care in patients with refractory, unresectable microsatellite stable (MSS)/mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC), a population long considered resistant to immunotherapy. This study is being conducted as a cooperative group trial led by the Canadian Cancer Trials Group (CCTG) from Canada and run across Canada, France, Australia and New Zealand. More than 100 sites will participate across the academic cooperative networks of CCTG, GI Cancer Trials in Australia and France’s Partenariat de Recherche en Oncologie Digestive (PRODIGE) consortium (including Unicancer, GERCOR and FFCD). The BATTMAN (CO.33) trial serves as the registrational-enablin

Klarna Agrees to $1.7 Billion Transaction Supporting up to $40B+ of Lending1.4.2026 13:19:00 CEST | Press Release

Klarna, the global digital bank and flexible payments provider, has entered into a new capital efficiency transaction in the form of a Significant Risk Transfer (SRT), covering $1.7 billion-worth of Euro denominated loans and freeing up capital to support continued growth. Klarna has entered into a three-year agreement with a consortium led by Värde Partners. This is Klarna's sixth SRT transaction and improves how effectively Klarna deploys its capital on a global basis. "Our banking license is one of our biggest competitive advantages," said Niclas Neglén, Klarna's Chief Financial Officer. "This is our largest and most efficient SRT transaction to date. These transactions allow us to maximize every unit of capital to support our continued momentum." The transaction follows Klarna’s recently announced $2 billion facility supporting $17B of US Financing expansion. About Klarna Klarna is a global digital bank and flexible payments provider. With over 118 million global active Klarna user

Americhem Launches nDryve™: PFAS-Free In-Melt Technology Platform for Functional Fibers1.4.2026 13:00:00 CEST | Press Release

Americhem, Inc., a global polymer solutions provider, today announced the launch of nDryve™, a PFAS-free, in-melt surface-modifying technology platform designed to deliver durable multi-fluid repellency against alcohol and other low-surface-energy fluids in fiber systems. As global regulations accelerate the phase-out of per- and polyfluoroalkyl substances (PFAS), manufacturers are under increasing pressure to maintain barrier performance without fluorinated chemistries. nDryve™ was developed to address this shift, offering a PFAS-free, in-melt alternative to conventional surface applied treatments. Engineered for Performance Without PFAS Often referred to as “forever chemicals,” PFAS have come under heightened regulatory scrutiny due to their persistence and potential environmental and health impacts. nDryve™ integrates directly into the polymer during melt processing, embedding surface-modifying functionality within the fiber matrix rather than relying on removable finishes. By engin

Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in Weight Loss and Beyond1.4.2026 13:00:00 CEST | Press Release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced a strategic partnership with Sihuan Pharmaceutical Holdings Group Ltd. (Sihuan Pharmaceutical; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s leading fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies across multiple disease areas, including weight loss, leveraging complementary strengths to drive synergies and establish a long-term strategic partnership. Sihuan Pharmaceutical highly values the strength of Biocytogen’s technology platforms. In this collaboration, Biocytogen will leverage its integrated platforms, including proprietary target-humanized mouse models and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye